Others have also demonstrated anticancer effects of pterostilbene in prostate cancer through multiple mechanisms, which include reduction of prostate-specific antigen, promotion of apoptosis, alteration of cell cycle and inhibition of cell growth [53–55]. This evidence concerns the gene KLK3 and prostate cancer.